Starsource Multitrade

Starsource Multitrade FCF/Dluh

Poměr Volného Cashflow k Dluhům společnosti Starsource Multitrade (506365.BO) k datu 16. 10. 2026.

FCF/Dluh

0,00

Poslední aktualizace:

Poměr Volného Cashflow k Dluhům společnosti Starsource Multitrade je 2026 0,00 . Poměr Volného Cashflow k Dluhům společnosti Starsource Multitrade byl 2025 -282 450,00 % . Klesá tak o % vyšší než v předchozím roce.

Tato data přes Eulerpool API

100 000 požadavků/měs. zdarma · bez karty

Starsource Multitrade Analýza akcií

Co dělá Starsource Multitrade? Starsource Multitrade Ltd, identified by the ticker symbol 506365.BO and ISIN INE320M01019, is a corporate entity registered in India with its headquarters located in Mumbai, Maharashtra. The company was originally established through an initial public offering on January 2, 1995. While the specific sector and industry classifications are currently listed as not applicable, the company's operational history and strategic direction are closely tied to its former identity as Chemo Pharma Laboratories Ltd. This previous incarnation operated within the pharmaceutical industry, focusing on the development and distribution of healthcare products. However, the corporate landscape has shifted significantly, and the entity is no longer engaged in its original pharmaceutical activities. According to available information, the firm currently has no active operations within its traditional business lines. Instead, the organization is in a transitional phase, actively exploring new business opportunities to redefine its market presence. The strategic intent of the current management is to pivot away from pharmaceuticals and acquire businesses in the power and chemicals sectors. This move represents a substantial change in the company's core focus, aiming to diversify its portfolio and enter entirely different industrial segments. The company's official website, https://www.thechemopharmalaboratoriesltd.com/, reflects its historical branding, although the operational reality has evolved. Investors and stakeholders monitoring the company should note that the absence of current operations means that recent financial performance may not reflect traditional revenue streams associated with pharmaceutical manufacturing or sales. The focus is currently on strategic acquisitions and business development rather than organic growth from existing products. The transition from a pharmaceutical manufacturer to a holding or investment vehicle targeting power and chemical assets suggests a long-term restructuring plan. Until new acquisitions are finalized and integrated, the company remains in a state of exploration and preparation. The headquarters in Mumbai serves as the administrative center for these strategic discussions and future operational planning. The lack of a defined sector classification further underscores the company's current status as an entity in flux, waiting for new business units to be acquired and operationalized. This profile highlights the significant shift from its historical roots in healthcare to its current ambitions in energy and industrial chemicals, marking a distinct chapter in the company's corporate evolution. Starsource Multitrade je jednou z nejoblíbenějších společností na Eulerpool.com.

Často kladené otázky ohledně akcií Starsource Multitrade

Na Eulerpool najdete úplný historický vývoj Poměr Volného Cashflow k Dluhům Starsource Multitrade od roku 2006 – s ročními hodnotami, grafy a podrobnou analýzou.

FCF/Dluh měří procento celkového dluhu, které by mohlo být splaceno z volného cashflow. Je to přísnější měřítko než OCF/Dluh, protože zohledňuje kapitálové výdaje.

Dobrá hodnota se liší podle odvětví a fáze vývoje společnosti. Na Eulerpool můžete porovnat Starsource Multitrade společnosti Poměr Volného Cashflow k Dluhům s porovnatelnými společnostmi a průměrem odvětví, abyste určili, zda je atraktivní.

Tato data přes Eulerpool API

100 000 požadavků/měs. zdarma · bez karty

Páka — Starsource Multitrade

Všechny klíčové ukazatele — Starsource Multitrade